Net revenue in Q4 2025 increased by 47% year-over-year to $44.5 million; Net revenue in FY 2025 increased by 25% year-over-year to $146.6 ...

Cronos Group Inc. (NASDAQ:CRON) is one of the Low Risk Penny Stocks to Buy Now. On February 26, Cronos Group Inc.

For years, North American cannabis investors have endured a brutal hangover. Cronos Group (NASDAQ:CRON), once a darling of the 2018-2019 marijuana mania, watched its share price collapse more than 95% ...

Cronos Group (NASDAQ: CRON) stock jumped 9.4% through 11:30 a.m. ET Tuesday after beating Wall Street forecasts for Q3 earnings this morning. Heading into the report, analysts expected Cronos to do ...

For its second quarter, Cronos -- which reports in U.S. dollars -- took in nearly $27.8 million in revenue, a figure almost 50% higher than the $19 million it earned in the same period of 2023. On a ...

Shares of Cronos Group (NASDAQ: CRON) were sinking 4.1% lower as of 10:57 a.m. ET on Tuesday and fell as much as 5.7% earlier in the day. The decline came after the U.S. Drug Enforcement ...

Cronos Group (NASDAQ:CRON) reported what executives described as a record year in 2025, with organic net revenue growth of 25 ...

Cronos Group Inc. (NASDAQ:CRON) is among the 11 Best Pot Stocks to Buy According to Hedge Funds. On February 24, TD ...

TORONTO, June 20, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, announced an expansion of Cronos Growing Company (“GrowCo”).

Cronos Group’s smaller size and production capacity would be less of an issue if its market cap were not the third largest of firms listed in Figure 5. This lofty valuation makes it even harder for ...

Cronos Group swung to a loss in the fourth quarter as foreign exchange losses offset revenue growth. The cannabis company on Thursday posted a net loss of $491,000, or zero cents a share, compared ...